FLGT analyst estimates
Fulgent Genetics (FLGT) analyst ratings, the average price target and its range, and every firm's latest call.
FLGT analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Aug 4, 2026 | Piper Sandler | Fulgent Genetics price target raised to $19 from $15 at Piper Sandler | $19.00 |
| May 5, 2026 | Piper Sandler | Fulgent Genetics price target lowered to $15 from $30 at Piper Sandler | $15.00 |
| Nov 14, 2025 | Raymond James | Fulgent Genetics (FLGT) PT Raised to $36 at Raymond James | $36.00 |
| Aug 5, 2025 | UBS | Fulgent Genetics upgraded to Buy from Neutral at UBS | $30.00 |
| Aug 4, 2025 | Piper Sandler | Fulgent Genetics price target lowered to $21 from $23 at Piper Sandler | $21.00 |
| May 5, 2025 | Raymond James | Fulgent Genetics price target raised to $25 from $24 at Raymond James | $25.00 |
| Dec 8, 2022 | Piper Sandler | Piper Sandler Downgrades Fulgent Genetics to Neutral, Lowers Price Target to $40 | $40.00 |
| Nov 18, 2022 | Raymond James | Raymond James Initiates Coverage On Fulgent Genetics with Outperform Rating, Announces Price Target of $45 | $45.00 |
| Nov 14, 2022 | Credit Suisse | Credit Suisse Maintains Outperform on Fulgent Genetics, Lowers Price Target to $50 | $50.00 |
| May 15, 2022 | Piper Sandler | Fulgent Genetics price target lowered to $70 from $85 at Piper Sandler | $70.00 |
- 1 firms rate FLGT: 0 buy, 1 hold, 0 sell.
- The average price target is $19.00 from 1 analysts, from $19.00 to $19.00.
Updated 2026-11-07 11:53 UTC